| ABO |
P16442
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
Enzyme
|
|
0.427 |
0.885 |
| HLA-DRB3 |
P79483
|
major histocompatibility complex, class II, DR beta 3
|
Immune response
|
|
0.570 |
0.885 |
| HLA-DRB4 |
P13762
|
major histocompatibility complex, class II, DR beta 4
|
Immune response
|
|
0.565 |
0.846 |
| IBD2 |
|
inflammatory bowel disease 2
|
|
|
0.805 |
0.154 |
| IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
| IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
| IFNB1 |
P01574
|
interferon beta 1
|
|
|
0.421 |
0.846 |
| COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
| NM |
|
neutrophil migration
|
|
|
0.473 |
0.808 |
| RNASE2 |
P10153
|
ribonuclease A family member 2
|
|
|
0.621 |
0.692 |
| RNASE3 |
P12724
|
ribonuclease A family member 3
|
|
|
0.490 |
0.808 |
| TRBV20OR9-2 |
|
T cell receptor beta variable 20/OR9-2 (non-functional)
|
|
|
0.403 |
0.923 |
| CDR3 |
|
Cerebellar degeneration-related autoantigen-3
|
|
|
0.472 |
0.808 |
| TAM |
|
Myeloproliferative syndrome, transient (transient abnormal
|
|
|
0.528 |
0.731 |
| MBL3P |
|
mannose-binding lectin family member 3, pseudogene
|
|
|
0.518 |
0.769 |
| IGAN1 |
|
IgA nephropathy
|
|
|
0.524 |
0.808 |
| HT |
|
Hashimoto thyroiditis
|
|
|
0.505 |
0.731 |
| PWAR1 |
|
Prader Willi/Angelman region RNA 1
|
|
|
0.490 |
0.769 |
| IRGM |
A1A4Y4
|
immunity related GTPase M
|
|
|
0.617 |
0.538 |
| LINC01193 |
|
long intergenic non-protein coding RNA 1193
|
|
|
0.565 |
0.692 |
| MIR125A |
|
microRNA 125a
|
|
|
0.480 |
0.769 |
| MIR126 |
|
microRNA 126
|
|
|
0.447 |
0.846 |
| MIR142 |
|
microRNA 142
|
|
|
0.480 |
0.846 |
| MIR143 |
|
microRNA 143
|
|
|
0.462 |
0.885 |
| MIR146A |
|
microRNA 146a
|
|
|
0.398 |
0.885 |